Michael Kelly, MD, PhD
Professor of Pediatrics
Northeast Ohio Medical University
Chief Medical Officer
Lymphangiomatosis & Gorham Stout Disease Alliance (LGDA)
Dr. Michael Kelly joined the LGDA and LMI in June of 2020 in a newly created position, Chief Medical Officer, where he will provide strategic oversight for foundation initiatives related to patient care and clinical and translational research.
Dr. Kelly attended the University of Cincinnati in 1980-1985, staying on to finish his MD, PhD in 1993. Dr. Kelly then completed his Pediatric residency and Hematology/Oncology fellowship at Washington University in St. Louis in 1998. He was the Pediatric Cancer Program Director at the Medical College of Wisconsin, Children’s Hospital of Wisconsin and most recently the Chief Research Officer at Akron Children’s Hospital.
Dr. Kelly’s research has focused on developing new, “first in children” therapies for pediatric cancer and vascular anomalies. He has over twenty years’ experience in the care of children and adults with vascular anomalies. In his role as CMO, Dr. Kelly will help organize and strengthen national and international collaborations that promote our understanding of complex lymphatic anomalies (CLAs) with the goal of providing more effective and safer therapies for children and adults with CLAs.